October 2025

Global pharmaceutical giant Eli Lilly and Company has announced plans to invest over USD 1 billion in India to expand its manufacturing capabilities and strengthen its presence in one of the world’s fastest-growing healthcare markets.

Wockhardt announced the submission of New Drug Application (NDA) to the U.S. Food and Drug Administration (US FDA) for its novel antibacterial agent Zidebactam-Cefepime injection

M.Pharm in Pharmaceutical Sciences with first division from a recognized institute/university. 5-10 years of experience in pharmaceutical industry in formulation development and characterization.

Guest Faculty on consolidated amount will be empanelled on honorarium basis Rs. 40,000/- per month ending 11 month or filling up of posts through regular recruitment or till further orders

D.Pharm / B.Pharm. or D.Pharm. (Ay.) / B.Pharm. (Ay.) from a recognized college or university. Experience in AYUSH Pharmacy.

B.Sc. / M.Sc. (Life Science or Nursing) / B.Pharm / MPH / M.Pharm / (regular) / from recognized university. Candidates must have minimum of 2 years of experience with bench work related to research and diagnostics.

Postgraduate degree in Basic Science (Life Sciences, Pharmacology, Toxicology, Public Health, Biochemistry, allied subjects) from a recognized university

Ph.D. in pharmacy or biological sciences or equivalent from a recognized University. Candidate with experience in the nanoformulations, cell culture studies and animal handling will be preferred.

ICMR funded project titled Centre for Advanced Research on Addictive Behaviours (CAR-AB) : Implementation focused initiative for delivering evidence-based interventions targeting excessive and problematic use of technology (smartphone/ gaming/social media/ gambling/ screen time) and associated stress, depression, anxiety, addiction